REAL-WORLD TREATMENT PATTERNS OF OMALIZUMAB IN CHRONIC IDIOPATHIC/SPONTANEOUS URTICARIA (CIU/CSU) PATIENTS IN THE UNITED STATES

被引：0
|
作者：
Eghrari-Sabet, J.
Sher, E.
Lefebvre, P.
Pilon, D.
Zhdanava, M.
Balp, M.
Kavati, A.
Ortiz, B.
Bernstein, J.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2017年 / 119卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P162
引用
收藏
页码：S42 / S42
页数：1
相关论文
共 50 条
  • [31] Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
    Martin Metz
    Zahava Vadasz
    Emek Kocatürk
    Ana M. Giménez-Arnau
    Clinical Reviews in Allergy & Immunology, 2020, 59 : 38 - 45
  • [32] Effectiveness of Hydroxychloroquine and Omalizumab in Chronic Spontaneous Urticaria: A Real-World Study
    Khan, Najeeb
    Epstein, Tolly G.
    DuBuske, Ilona
    Strobel, Maria
    Bernstein, David I.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (12): : 3300 - 3305
  • [33] Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
    Metz, Martin
    Vadasz, Zahava
    Kocaturk, Emek
    Gimenez-Arnau, Ana M.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2020, 59 (01) : 38 - 45
  • [34] Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria A Meta-analysis of "Real-world" Evidence
    Tharp, Michael D.
    Bernstein, Jonathan A.
    Kavati, Abhishek
    Ortiz, Benjamin
    MacDonald, Karen
    Denhaerynck, Kris
    Abraham, Ivo
    Lee, Christopher S.
    JAMA DERMATOLOGY, 2019, 155 (01) : 29 - 38
  • [35] Baseline Characteristics of Patients with Refractory Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU) Enrolled in a Phase III, Randomized, Placebo-Controlled Trial of Omalizumab
    Rosen, Karin
    Hsieh, Hsin-Ju
    Georgiou, Panayiotis
    Casale, Thomas
    Maurer, Marcus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB29 - AB29
  • [36] Clinical profile of patients with refractory chronic idiopathic/spontaneous urticaria (CIU/CSU) in phase III omalizumab studies: Analyses according to the presence or absence of angioedema
    Sofen, Howard
    Mendelson, Meryl
    Vu, Julie
    Kianifard, Farid
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB43 - AB43
  • [37] Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: Meta-Analysis of "real-world" evidence
    Tharp, M. D.
    Lee, C. S.
    Mac Donald, K. M.
    Denhaerynck, K.
    Abraham, I. L.
    Ortiz, B.
    Kavati, A.
    Bernstein, J. A.
    ALLERGY, 2018, 73 : 224 - 224
  • [38] REAL LIFE EXPERIENCE WITH OMALIZUMAB IN THE TREATMENT OF CHRONIC SPONTANEOUS URTICARIA (CSU) IN A METROPOLITAN SPECIALIST CLINIC
    Katelaris, Constance H.
    Perram, Fiona A.
    Burton, Pamela K.
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 29 - 29
  • [39] Patient preferences for health: the value patients place on differential severity of chronic spontaneous (Idiopathic) urticaria (CSU/CIU)
    Stull, D.
    Mcbride, D.
    Balp, M-M
    ALLERGY, 2014, 69 : 317 - 317
  • [40] Omalizumab in Chronic Spontaneous Urticaria: A Real-World Study on Effectiveness, Safety and Predictors of Treatment Outcome
    Chen, Jiaoquan
    Ou, Shanshan
    Wu, Weihong
    Zou, Hui
    Li, Huaping
    Zhu, Huilan
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2024, 17 : 1799 - 1808
12345